Related Experiment Video

Updated: Sep 27, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Marked decline in pertussis followed reintroduction of pertussis vaccination in Sweden

P Olin, H.O. Hallander

    Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
    |March 13, 2003
    PubMed

    Insights

    Sweden introduced acellular pertussis vaccines for children in 1996. This decision followed the withdrawal of whole-cell vaccines 17 years earlier, aiming to improve pertussis (whooping cough) immunization coverage.

    Area of Science:

    • Pediatrics
    • Immunology
    • Public Health

    Background:

    • The Swedish vaccination program transitioned from whole-cell pertussis vaccines to acellular pertussis vaccines in January 1996.
    • This change occurred 17 years after the discontinuation of whole-cell pertussis vaccine use in 1979.

    Purpose of the Study:

    • To evaluate the impact of introducing acellular pertussis vaccine on immunization coverage rates in Sweden.

    Main Methods:

    • The study likely involved analyzing vaccination coverage data following the program change.
    • Data collection focused on children receiving immunisation at 3, 5, and 12 months of age.

    Main Results:

    • Initial data indicated a rapid increase in pertussis vaccination coverage within months of the acellular vaccine's introduction.
    • The acellular pertussis vaccine was successfully integrated into the national immunization schedule.

    Conclusions:

    • The introduction of acellular pertussis vaccine into the Swedish program in 1996 was associated with high and rapid uptake.
    • This strategic shift in vaccine type aimed to enhance protection against pertussis in the pediatric population.

    More Related Videos

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014

    Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections16:56

    Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

    Published on: August 30, 2014

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
    Poliomyelitis01:17

    Poliomyelitis

    Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
    Infectious Diseases and Their Occurrence01:28

    Infectious Diseases and Their Occurrence

    Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...